New England Journal of Medicine

Vol. 394, Issue 1 Issue 1 2026
20
Articles

Articles in this Issue

A Threat to Evidence-Based Vaccine Policy and Public Health Security at the FDA

Robert M. Califf, Andrew C. von Eschenbach, Michael A. Friedman et al. Jan 01, 2026 pp. 4-6 10.1056/nejmp2517497

Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC

Pasi A. Jänne, David Planchard, Kunihiko Kobayashi et al. Jan 01, 2026 pp. 27-38 10.1056/nejmoa2510308

Navigating the Evolving Landscape of <i>EGFR</i> -Mutated NSCLC

Roy S. Herbst Jan 01, 2026 pp. 87-91 10.1056/nejme2514042

Osteogenesis Imperfecta

Stefanie Stasek, Oliver Semler Jan 01, 2026 pp. 78-78 10.1056/nejmicm2510135

Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction

Jan 01, 2026 pp. 96-98 10.1056/nejmc2515452

More on Long-Term Outcomes of the DanGer Shock Trial

Jan 01, 2026 pp. 102-103 10.1056/nejmc2514551

Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab

Shaji Kumar, María-Victoria Mateos, Jing Christine Ye et al. Jan 01, 2026 pp. 51-61 10.1056/nejmoa2514752

Periumbilical Erythema Migrans

Paul Bellmann, Barbara C. Böckle Jan 01, 2026 10.1056/nejmicm2512486

Monoclonal Gammopathy of Undetermined Significance

Jan 01, 2026 pp. 100-102 10.1056/nejmc2515512

Breaking Barriers in Mucopolysaccharidosis Type II

Can Ficicioglu Jan 01, 2026 pp. 91-92 10.1056/nejme2514617

Sacituzumab Tirumotecan in EGFR-TKI–Resistant, <i>EGFR</i> -Mutated Advanced NSCLC

Wenfeng Fang, Lin Wu, Xiangjiao Meng et al. Jan 01, 2026 pp. 13-26 10.1056/nejmoa2512071

From Patients to Consumers — The Corporatization of Ambulatory Care

Ambar La Forgia Jan 01, 2026 pp. 1-3 10.1056/nejmp2415483

Closing the Gap

Colin H. McLeish, Allan C. Gelber, Howard M. Lederman et al. Jan 01, 2026 pp. 79-85 10.1056/nejmcps2506820

Direct-Acting Antiviral Agents in Hepatitis C–Associated Indolent Lymphomas

Michele Merli, Elisa Genuardi, Silvia Zibellini et al. Jan 01, 2026 pp. 93-96 10.1056/nejmc2513023

Statistics in Medicine — What’s in an Estimand?

Andrea B. Troxel, Constantine A. Gatsonis, Joseph W. Hogan et al. Jan 01, 2026 pp. 6-9 10.1056/nejmp2513633

Who Can See Their PCP?

Jan 01, 2026 10.1056/nejmp2514239

Congenital Zika Syndrome

Felipe Baccin, Maria A. Montenegro Jan 01, 2026 10.1056/nejmicm2511220

Targeting <i>APOC3</i> with Olezarsen in Moderate Hypertriglyceridemia

Jan 01, 2026 pp. 98-100 10.1056/nejmc2515639

Where Do I Put This?

Danielle Chammas Jan 01, 2026 pp. 9-11 10.1056/nejmp2507796

An Intravenous Brain-Penetrant Enzyme Therapy for Mucopolysaccharidosis II

Joseph Muenzer, Barbara K. Burton, Paul Harmatz et al. Jan 01, 2026 pp. 39-50 10.1056/nejmoa2508681

All Issues

Journal Info

Publisher Massachusetts Medical Society
ISSN 0028-4793
E-ISSN 0096-6762
Subject Social Sciences
Language English
View Full Journal Page